


| Key | % Net Assets |
|---|---|
| 4.7% | |
| 3.8% | |
| 3.3% | |
| 3.0% | |
| 85.2% |
| Name | % Net Assets |
|---|---|
| Citigroup | 4.7% |
| Microsoft | 3.8% |
| Morgan Stanley | 3.3% |
| Wyeth | 3.0% |
| Wells Fargo | 3.0% |
| UnitedHealth | 3.0% |
| Sprint Nextel | 3.0% |
| American International | 2.7% |
| Exelon | 2.6% |
| Genzyme | 2.6% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 544.90p |
| Currency | GBP |
| Change | -0.80p |
| % | -0.15% |
| YTD change | -8.20p |
| YTD % | -1.48% |
| Fund Inception | 19/02/2001 |
|---|---|
| Fund Manager | Maximillian Anderl |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £500 |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research